1. Home
  2. ZNTL vs LEE Comparison

ZNTL vs LEE Comparison

Compare ZNTL & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$4.42

Market Cap

156.7M

Sector

Health Care

ML Signal

HOLD

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$8.85

Market Cap

160.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZNTL
LEE
Founded
2014
1890
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
156.7M
160.1M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
ZNTL
LEE
Price
$4.42
$8.85
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$5.80
N/A
AVG Volume (30 Days)
460.6K
63.3K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
18.03
N/A
EPS
N/A
N/A
Revenue
N/A
$543,955,000.00
Revenue This Year
N/A
$5.48
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$3.34
52 Week High
$3.95
$9.97

Technical Indicators

Market Signals
Indicator
ZNTL
LEE
Relative Strength Index (RSI) 78.56 54.41
Support Level $1.31 $8.07
Resistance Level N/A $9.59
Average True Range (ATR) 0.32 0.64
MACD 0.14 -0.05
Stochastic Oscillator 96.49 64.36

Price Performance

Historical Comparison
ZNTL
LEE

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: